Artemether–lumefantrine with or without single-dose primaquine and sulfadoxine–pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, Mali
Open Access
- 2 May 2024
- journal article
- research article
- Published by Elsevier in The Lancet Microbe
- Vol. 5 (7) , 633-644
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Wellcome Trust (218676/Z/19/Z/WT)
- Bill & Melinda Gates Foundation (INV-002098)
- European Research Council (ERC-CoG 864180)
This publication has 23 references indexed in Scilit:
- Tafenoquine co-administered with dihydroartemisinin–piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety studyThe Lancet Infectious Diseases, 2023
- Transmission Blocking Activity of Low-dose Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparumClinical Infectious Diseases, 2022
- Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trialThe Lancet Microbe, 2022
- Pyronaridine–artesunate or dihydroartemisinin–piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trialThe Lancet Microbe, 2022
- Evidence of Artemisinin-Resistant Malaria in AfricaNew England Journal of Medicine, 2021
- Malaria eradication within a generation: ambitious, achievable, and necessaryThe Lancet, 2019
- Transmission-blocking Effects of Primaquine and Methylene Blue Suggest Plasmodium falciparum Gametocyte Sterilization Rather Than Effects on Sex RatioClinical Infectious Diseases, 2019
- Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trialThe Lancet Infectious Diseases, 2018
- Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trialThe Lancet Infectious Diseases, 2016
- Moderate Effect of Artemisinin‐Based Combination Therapy on Transmission ofPlasmodium falciparumThe Journal of Infectious Diseases, 2006